100 Start-ups registered with ISRO to work in the Space Tech field

From our special correspondent

Daijiworld Media Network

Bangalore, November 17: Indian Space Research Organization (ISRO) Chairman S Somanath said on Thursday that about 100 start-ups are registered with them and are working closely in various fields of the space sector.

Addressing a plenary session in Bengaluru during the Bengaluru Tech Summit 2022 on “R&D from India – Innovation for global impact” on Thursday, he said ISRO had signed memorandums of understanding with companies to work closely together, including hands on space technology and construction processes from start to finish. He said that a significant number of companies have the potential to become big players in the space sector and that ISRO plays the role of facilitator and helper in building technologies.

Somanath said that out of 100 start-ups, at least 10 are working on developing satellites and rockets. The ISRO President announced that the Chandrayaan-3 mission will be in orbit in a few months, adding that ISRO is working closely with NASA in the fields of space technology. He said the computer that was used in the rocket for the mission was made in India. In his quick presentation, he said that space tourism has taken hold in the world, with start-ups showing interest in various applications that impact day-to-day activities. He said ISRO plays an important role in smart city projects and smart manufacturing processes.

He said some of the areas ISRO is working on include the return of satellite technology, propulsion systems used in the manufacture of engines that have been successfully tested.

Green and hybrid propulsion system, nuclear propulsion, launch of small rockets with the use of additive technologies, energy storage systems, functional materials, carbon fiber technology, electronic devices, robotics, drone technologies, quantum technology used in encryption and disruptive technologies.

Previously, the 2020 Nobel Prize in Chemistry laureate and French microbiologist, Dr. Emmanuelle Charpentier, who is Scientific Director and Managing Director of the Max Planck Unit, Pathogen Science in Berlin, gave a presentation on “A research journey towards CRISPR-Cas genome engineering technology”.